Clinical trial

Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

NCT07427576

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2025-03-31

PhaseN/A

Study timeline

Study start (actual)2025-03-31Date precision: day

Registry last updated2026-02-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mite Allergyunresolved

Dermatophagoides Farinae Allergyunresolved

Dermatophagoides Pteronyssinus Allergyunresolved

Rhinitis, Allergicunresolved

Asthmaunresolved

Rhinoconjunctivitisunresolved

Interventions

Clustoid® Max ForteBIOLOGICAL

Sponsors & collaborators

Inmunotek S.L.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07427576 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.